Whole Shine Medical Technology Past Earnings Performance
Past criteria checks 0/6
Whole Shine Medical Technology's earnings have been declining at an average annual rate of -39.2%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 24% per year.
Key information
-39.2%
Earnings growth rate
-39.2%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 24.0% |
| Return on equity | -12.5% |
| Net Margin | -12.5% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses Breakdown
How Whole Shine Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 757 | -94 | 299 | 16 |
| 30 Sep 23 | 613 | -227 | 290 | 19 |
| 30 Jun 23 | 602 | -219 | 288 | 17 |
| 31 Mar 23 | 548 | -232 | 269 | 14 |
| 01 Jan 23 | 501 | -257 | 266 | 15 |
| 30 Sep 22 | 503 | -91 | 234 | 10 |
| 30 Jun 22 | 331 | -116 | 169 | 10 |
| 31 Mar 22 | 234 | -98 | 120 | 9 |
| 31 Dec 21 | 168 | -76 | 73 | 10 |
| 30 Sep 21 | 133 | -268 | 12 | 8 |
| 30 Jun 21 | 134 | -255 | 46 | 8 |
| 31 Mar 21 | 122 | -299 | 50 | 8 |
| 31 Dec 20 | 114 | -297 | 51 | 8 |
| 30 Sep 20 | 116 | -6 | 76 | 8 |
| 30 Jun 20 | 117 | -10 | 48 | 8 |
| 31 Mar 20 | 124 | 16 | 62 | 8 |
| 31 Dec 19 | 155 | 7 | 88 | 9 |
| 30 Sep 19 | 234 | 3 | 167 | 10 |
| 30 Jun 19 | 321 | 20 | 180 | 11 |
| 31 Mar 19 | 435 | 36 | 191 | 11 |
| 31 Dec 18 | 422 | 37 | 183 | 10 |
| 30 Sep 18 | 381 | 60 | 127 | 11 |
| 30 Jun 18 | 317 | 49 | 116 | 12 |
| 31 Mar 18 | 209 | 58 | 96 | 9 |
| 31 Dec 17 | 195 | 72 | 83 | 7 |
| 30 Sep 17 | 149 | 19 | 83 | 4 |
| 30 Jun 17 | 150 | 34 | 79 | 0 |
| 31 Mar 17 | 124 | 18 | 77 | 0 |
| 31 Dec 16 | 120 | 16 | 76 | 0 |
| 30 Sep 16 | 116 | 60 | 60 | 0 |
| 30 Jun 16 | 114 | 59 | 62 | 0 |
| 31 Mar 16 | 139 | 81 | 55 | 0 |
| 31 Dec 15 | 147 | 90 | 54 | 0 |
| 30 Sep 15 | 162 | 79 | 44 | 0 |
| 30 Jun 15 | 153 | 70 | 45 | 0 |
| 31 Mar 15 | 158 | 56 | 47 | 0 |
| 31 Dec 14 | 161 | 47 | 47 | 0 |
| 30 Sep 14 | 157 | 32 | 59 | 0 |
| 30 Jun 14 | 165 | 33 | 59 | 0 |
| 31 Mar 14 | 176 | 38 | 63 | 0 |
| 31 Dec 13 | 185 | 39 | 66 | 0 |
| 30 Sep 13 | 187 | 44 | 77 | 0 |
| 30 Jun 13 | 223 | 47 | 76 | 0 |
Quality Earnings: 002622 is currently unprofitable.
Growing Profit Margin: 002622 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002622 is unprofitable, and losses have increased over the past 5 years at a rate of 39.2% per year.
Accelerating Growth: Unable to compare 002622's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002622 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-1%).
Return on Equity
High ROE: 002622 has a negative Return on Equity (-12.53%), as it is currently unprofitable.